Increased plasma xanthine oxidoreductase activity deteriorates coronary artery spasm.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 20 03 2018
accepted: 15 06 2018
pubmed: 25 6 2018
medline: 21 3 2019
entrez: 25 6 2018
Statut: ppublish

Résumé

Increased reactive oxygen species (ROS) contributes to the development of endothelial dysfunction, which is involved in coronary artery spasm (CAS). Xanthine oxidoreductase (XOR) plays a pivotal role in producing both uric acid and ROS. However, the association between plasma XOR activity and CAS has not been elucidated. The aim of this study was to investigate whether plasma XOR activity is associated with CAS. We measured XOR activity in 104 patients suspected for CAS, who presented without significant coronary artery stenosis and underwent intracoronary acetylcholine provocation tests. CAS was provoked in 44 patients and they had significantly higher XOR activity as compared with those without CAS. The patients were divided into three groups based on the XOR activity. The prevalence rate of CAS was increased with increasing XOR activity. A multivariate logistic regression analysis showed that the 3rd tertile group exhibited a higher incidence of CAS as compared with the 1st tertile group [odds ratio (OR) 6.9, P = 0.001) and the 2nd tertile group (OR 3.2, P = 0.033) after adjustment for conventional CAS risk factors, respectively. The C index was significantly improved by the addition of XOR activity to the baseline model based on CAS risk factors. Furthermore, the 3rd tertile group had the highest incidence of severe spasm defined as total obstruction, flow-limiting stenosis, diffuse spasm, multivessel spasm, and/or lethal arrhythmia. This is a first report to elucidate the association of plasma XOR activity with CAS. Increased plasma XOR activity is significantly associated with CAS.

Identifiants

pubmed: 29936631
doi: 10.1007/s00380-018-1207-4
pii: 10.1007/s00380-018-1207-4
doi:

Substances chimiques

Biomarkers 0
Xanthine Dehydrogenase EC 1.17.1.4

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Subventions

Organisme : KAKENHI
ID : 17K15984
Organisme : KAKENHI
ID : 25461039
Organisme : KAKENHI
ID : 18K08025
Organisme : KAKENHI
ID : 18K08059

Références

Circulation. 2006 Dec 5;114(23):2508-16
pubmed: 17130343
Biochim Biophys Acta. 2014 Sep;1842(9):1502-17
pubmed: 24882753
Redox Biol. 2013 Jun 10;1:353-8
pubmed: 24024171
Int J Cardiol. 2010 Apr 15;140(2):175-81
pubmed: 19108908
Circulation. 2003 Mar 18;107(10):1383-9
pubmed: 12642358
Int J Cardiol. 2013 Sep 30;168(2):934-45
pubmed: 23218570
J Cardiol. 2013 Dec;62(6):354-60
pubmed: 23838556
J Am Coll Cardiol. 2015 Sep 8;66(10):1105-15
pubmed: 26337988
J Biol Chem. 1991 Mar 5;266(7):4244-50
pubmed: 1847917
J Biol Chem. 2013 Sep 20;288(38):27138-49
pubmed: 23913681
Heart Vessels. 2014 Mar;29(2):186-90
pubmed: 23552902
Atherosclerosis. 2014 Dec;237(2):562-7
pubmed: 25463089
Histochemistry. 1993 Sep;100(3):215-22
pubmed: 8244772
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1767-75
pubmed: 16002741
Intern Med. 2014;53(23):2663-70
pubmed: 25447646
Circ Cardiovasc Interv. 2009 Apr;2(2):97-104
pubmed: 20031702
Circ Res. 2017 Feb 17;120(4):713-735
pubmed: 28209797
J Cardiol. 2008 Feb;51(1):2-17
pubmed: 18522770
Int J Cardiol. 2017 Feb 1;228:151-157
pubmed: 27865177
J Am Coll Cardiol. 1994 Feb;23(2):352-7
pubmed: 8294686
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Dec 15;1039:51-58
pubmed: 27816314
Circulation. 2000 Mar 14;101(10):1102-8
pubmed: 10715255
Blood Press. 2014 Feb;23(1):3-16
pubmed: 24359485
Circulation. 2011 Oct 18;124(16):1774-82
pubmed: 22007100
J Cardiol. 2012 May;59(3):235-42
pubmed: 22398104
Kidney Int. 2005 May;67(5):1739-42
pubmed: 15840020
Circulation. 1993 Jul;88(1):43-54
pubmed: 8319355
Int J Med Sci. 2014 Aug 28;11(11):1161-71
pubmed: 25249785
J Am Coll Cardiol. 2011 Sep 13;58(12):1238-40
pubmed: 21903057
Am J Cardiol. 2001 Jul 15;88(2):188-91, A6
pubmed: 11448423
Vasc Health Risk Manag. 2009;5(1):265-72
pubmed: 19436671
J Am Coll Cardiol. 2017 Jul 11;70(2):212-229
pubmed: 28683969
Curr Pharm Des. 2005;11(32):4145-51
pubmed: 16375736
Med Sci Monit. 2016 Jul 17;22:2501-12
pubmed: 27423335
Sci Rep. 2016 Jan 27;6:19520
pubmed: 26814153

Auteurs

Ken Watanabe (K)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Tetsuro Shishido (T)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan. tshishid@med.id.yamagata-u.ac.jp.

Yoichiro Otaki (Y)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Tetsu Watanabe (T)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Takayuki Sugai (T)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Taku Toshima (T)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Tetsuya Takahashi (T)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Miyuki Yokoyama (M)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Daisuke Kinoshita (D)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Takayo Murase (T)

Radioisotope and Chemical Analysis Center, Sanwa Kagaku Kenkyusho Co., Ltd, Mie, Japan.

Takashi Nakamura (T)

Pharmacological Study Group, Pharmaceutical Research Laboratories, Sanwa Kagaku Kenkyusho Co., Ltd, Mie, Japan.

Masahiro Wanezaki (M)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Harutoshi Tamura (H)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Satoshi Nishiyama (S)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Hiroki Takahashi (H)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Takanori Arimoto (T)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

So Yamauchi (S)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Tamon Yamanaka (T)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Takuya Miyamoto (T)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Isao Kubota (I)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Masafumi Watanabe (M)

Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH